The relationship between intensification of blood glucose-lowering therapies, health status and quality of life in type 2 diabetes: The Fremantle Diabetes Study Phase II.

Davis, Timothy M E; Bruce, David G; Curtis, Bradley H; Barraclough, Helen; Davis, Wendy A

Davis, Timothy M E; Bruce, David G; Curtis, Bradley H; Barraclough, Helen; Davis, Wendy A.

Afiliación

Davis TME; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia. Electronic address: tim.davis@uwa.edu.au.
Bruce DG; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.
Curtis BH; Eli Lilly Australia and New Zealand, 112 Wharf Rd, West Ryde, NSW, Australia.
Barraclough H; Eli Lilly Australia and New Zealand, 112 Wharf Rd, West Ryde, NSW, Australia.
Davis WA; Medical School, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia, Australia.

Diabetes Res Clin Pract ; 142: 294-302, 2018 Aug.

Article en En | MEDLINE | ID: mdl-29879496

Asunto(s)

Glucemia/metabolismo; Diabetes Mellitus Tipo 2/sangre; Calidad de Vida/psicología; Anciano; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Femenino; Humanos; Masculino

Palabras clave

Health status; Quality of life; Treatment intensification; Type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Glucemia / Diabetes Mellitus Tipo 2 Aspecto: Patient_preference Límite: Aged / Female / Humans / Male Idioma: En Revista: Diabetes Res Clin Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google